$PLUS

ePlus Reports First Quarter Fiscal Year 2027 Financial Results

ePlus (NASDAQ: PLUS) reported Q1 FY2027 results for the three months ended June 30, 2026. Net sales rose 1.0% to $649.1 million and services revenue rose 2.6% to $119.4 million, while gross profit fell 1.5% to $151.3 million. Net earnings from continuing ops declined 5.4% to $30.3 million and adjusted EBITDA fell 9.2% to $47.8 million. The company reiterated FY2027 mid-single-digit growth guidance and declared a $0.27 quarterly dividend.

Original reporting
Published Aug 4, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ePlus Reports First Quarter Fiscal Year 2027 Financial Results — source image
Decision brief

The 30-second read

$PLUSNeutralMed
01

Why it matters

Traders can reassess the balance between services momentum (managed services first $50M revenue quarter) and profitability headwinds (gross profit and adjusted EBITDA declines, margin compression). The company also flags product shipment delays tied to the memory chip shortage.

02

Market read

This is a company-specific earnings and guidance reiteration with segment-level detail, including managed services growth and consolidated margin/EBITDA declines.

03

What to watch

Large accounts receivable increase ($746.0M) and lower gross profit margin (23.3% vs 23.9%) could signal working-capital and profitability risks that investors may reprice.

Relevance 7/10Novelty 7/10Timing: after-hours earnings release, Aug. 4, 2026

Background

ePlus is a technology solutions provider with product and services segments, and it is reiterating FY2027 mid-single-digit growth guidance.

Company-level read

Ticker impact

$PLUSNeutralMedium confidence
Context

ePlus reported Q1 FY2027 results, including net sales of $649.1M, managed services revenue up to $51.3M, and reiterated mid-single-digit guidance.

Expected impact

Near-term bias modestly positive on services momentum, but overall valuation reaction likely tempered by weaker profitability metrics and margin compression.

Evidence & confidence

The release provides multiple directionally mixed datapoints: revenue and managed services growth versus declines in gross profit, operating income, and adjusted EBITDA, plus continued supply-chain delays from memory chip shortages.

Market effects

Reinforces a services-led IT solutions demand narrative (security and managed services) while highlighting ongoing hardware supply-chain constraints affecting shipments and lead times.

Limited direct regional read-through; primarily US-listed IT services demand and margin dynamics.

Memory chip shortage is cited as a continuing constraint, which can affect broader IT hardware supply and timing globally.

Counterpoint

The managed services revenue jump may not fully offset product and professional services margin pressure, so the quality of earnings could be weaker than the revenue growth suggests.

Key entities

  • ePlus inc.

    Reported Q1 FY2027 financial results and reiterated FY2027 mid-single-digit growth guidance, citing managed services growth and memory chip shortages.

  • Mark Marron

    CEO who commented on record sales, increased orders, managed services performance, and supply-chain delays.

Related articles

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.

$PLUSMed

ePlus (NASDAQ:PLUS) Surprises With Q2 CY2026 Sales

ePlus (NASDAQ:PLUS) reported Q2 CY2026 revenue of $649.1 million, up 1.9% year on year, exceeding market expectations. Non-GAAP profit was $1.28 per share, 11.8% above analysts’ consensus. The company cited extended lead times and shipment delays tied to an ongoing memory chip shortage.

$PLUSMed

EPLUS INC (PLUS): Results of Operations and Financial Condition

EPLUS INC (PLUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 5 ef20079242_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 ePlus Reports First Quarter Fiscal Year 2027 Financial Results Managed Services Delivers Strong Performance and Increases Recurring Revenue ~ Reiterates Fiscal 2027 Guidance ~ First Quarter of Fiscal Year 2027 ● Net sales

$PLUSMed

PageGroup & Oxford Nanopore: Markets live

PageGroup shares rose over 11% after it reported Q2 gross profit of £198m, down 0.2% year on year but ahead of analyst expectations, and said it sees signs of market normalisation. ME Group International gained about 11% after interim results showed flat £154m sales. Plus500 shares fell on weaker cash margin, and Oxford Nanopore dropped 12% after H1 sales missed expectations at £116.5m.

$PLUSMedAI 8/10

ePlus (NASDAQ:PLUS) Issues Earnings Results

ePlus (NASDAQ:PLUS) reported quarterly EPS of $1.00, slightly above analysts’ $0.98 consensus, and revenue of $576.17 million versus $569.25 million expected, according to FiscalAI. The stock fell $0.54 to $88.65 on Thursday. Institutional investors hold 93.8%.